| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 12/18/2002 | EP0930887B1 Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
| 12/18/2002 | EP0769018B1 Helicobacter proteins and vaccines |
| 12/18/2002 | CN1385210A Process for preparing Chinese medicine stasis-removing and fat-reducing pill |
| 12/18/2002 | CN1385203A Compound Chinese medicine preparation of damnacanthus |
| 12/18/2002 | CN1385201A Formula of solid antitussive soft-extract and preparation method thereof |
| 12/18/2002 | CN1385193A Traditional Chinese medicine having effects of reducing inflammation, stopping blooding, stopping pain, promoting blood circulation and promoting tissue regeneration |
| 12/18/2002 | CN1385186A Traditional Chinese medicine for treating arthralgia-syndrome due to wind-cold-dampress and formula and preparation process thereof |
| 12/18/2002 | CN1385185A Method for producing Naoxin'an Chinese medicinal capsule used for trating hemiparalysis, obstruction of qi in the chest and cardialgia |
| 12/18/2002 | CN1385180A Compound composite medicine for giving up drug-taking |
| 12/18/2002 | CN1385174A Forestfrog oil tonic |
| 12/18/2002 | CN1385170A Natural propolis nutrient liquor and process for preparing same |
| 12/18/2002 | CN1385169A Medicine composition for treating diabetes |
| 12/18/2002 | CN1385168A External used functional medicine whose Chinese medicine prescription intensified by snake macro-micro element |
| 12/18/2002 | CN1096278C Medicine for treating trigeminal neuralgia |
| 12/18/2002 | CN1096270C No scar scald treating ointment |
| 12/17/2002 | US6495735 Transgenic non-human mammals expressing DNA sequences encoding homologous complement restriction factors of a discordant mammalian species |
| 12/17/2002 | US6495526 Inhibitors of cell-cycle progression and uses related thereto |
| 12/17/2002 | US6495519 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
| 12/17/2002 | US6495364 Mx-1 conditionally immortalized cells |
| 12/17/2002 | US6495346 Do not react with foreign partners; amino acids inserted into proteins which naturally form dimers, mutated proteins only form complexes with themselves (homodimers) or with the mutated partner (heterodimers), not with nonmutated starting |
| 12/17/2002 | US6495161 Capsules containing such as islet of langerhans, hepatocytes, lymphocytes used for drugs or medical diagnosis, having strength, permeability, porosity and time release |
| 12/17/2002 | US6495146 Administering eimeria spores, oocysts and/or mixtures during incubation of poultry eggs; immunology |
| 12/17/2002 | US6495142 Administering a composition comprising a specified low-molecular weight chitosan and/or a derivative |
| 12/17/2002 | CA2083061C Peat-derived bioactive products and pharmaceutical and cosmetic compositions containing them |
| 12/12/2002 | WO2002099037A2 Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins |
| 12/12/2002 | WO2002099035A2 Chimeric alphavirus replicon particles |
| 12/12/2002 | WO2002098453A2 Orally administering parathyroid hormone and calcitonin |
| 12/12/2002 | WO2002098365A2 Conditioned cell culture media and uses thereof |
| 12/12/2002 | WO2002098361A2 T cell induced tissue repair and regeneration |
| 12/12/2002 | WO2002098278A2 Peripheral blood fibrocytes differentiation pathway and migration to wound sites |
| 12/12/2002 | WO2002077249A3 Type iii bacterial strains for use in medicine |
| 12/12/2002 | WO2002076508B1 Methods for delivering nucleic acid molecules into cells and assessment thereof |
| 12/12/2002 | WO2002074798A3 The genome of a bifidobacterium |
| 12/12/2002 | WO2002070552A3 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF |
| 12/12/2002 | WO2002065989A3 Aminoglycoside treatment for lysosomal storage diseases |
| 12/12/2002 | WO2002062967A3 Multipotent o-2a progenitors from the neurohypophysis |
| 12/12/2002 | WO2002061052A3 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 12/12/2002 | WO2002030983A3 Plasma fraction containing bikunin, method for the production thereof and use of the same |
| 12/12/2002 | WO2002026941A3 Primitive neural stem cells and method for differentiation of stem cells to neural cells |
| 12/12/2002 | WO2001089568A9 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 12/12/2002 | WO2001027303A9 Adeno-associated virus vectors encoding factor viii and methods of using the same |
| 12/12/2002 | US20020188349 Tissue engineered blood vessels and apparatus for their manufacture |
| 12/12/2002 | US20020188240 Process and apparatus for utilization of in vivo extracted plasma with tissue engineering devices, bioreactors, artificial organs, and cell therapy applications |
| 12/12/2002 | US20020188029 Methods of treating or preventing weight gain, obesity, and related disorders |
| 12/12/2002 | US20020187957 Time release reverse transcriptase inhibitors |
| 12/12/2002 | US20020187936 Methods of treating liver disease and liver damage with growth hormone and foxM1B |
| 12/12/2002 | US20020187551 Culturing and proliferating isolated Langerhans islets endocrine cells; obtain viable langerhans islets endocrine cells, incubate with cell propagation proteins, recover cells |
| 12/12/2002 | US20020187548 Method for identification of cell growth or differentiation factors |
| 12/12/2002 | US20020187543 Enhanced dispersion of adenoviral vectors by fusogenic membrane glycoproteins |
| 12/12/2002 | US20020187527 Generation of nucleotide sequence which can be used as tools of gene therapy; obtain cells, transform with expression vector, recover transformed cells, detect methyltransferase expression and methylated nucleotide sequences |
| 12/12/2002 | US20020187465 Treatment of cell proliferative disorders; obtain human, administer antiproliferative agent, monitor humans for reduction in tumor cells |
| 12/12/2002 | US20020187202 Natural nontoxic multicolor fluorescent protein dye from a marine invertebrate, compositions containing the said dye and its uses |
| 12/12/2002 | US20020187201 Process for the cure and control of diabetes mellitus using natural products from perna viridis |
| 12/12/2002 | US20020187200 Dietary supplement comprising lactoferrin and citrus pectin |
| 12/12/2002 | US20020187189 Proliposomal drug delivery system |
| 12/12/2002 | US20020187163 Herpes simplex virus comprising a mutation within the BstEII-EcoNI fragment of the BamHI x fragment of said virus; cancer vaccine |
| 12/12/2002 | US20020187157 Administering an amyloidogenic polypeptide or subsequence thereof to induces production of antibodies against the amyloidogenic polypeptide; treatment of Alzheimer's disease |
| 12/12/2002 | US20020187143 Methods and compositions for reducing immune response |
| 12/12/2002 | US20020187140 Two novel human cathepsin proteins |
| 12/12/2002 | US20020187135 Methods for inducing antigen-specific t cell tolerance |
| 12/12/2002 | US20020187134 Prebiotic and probiotic compositions and methods for their use in gut-based therapies |
| 12/12/2002 | US20020187125 Reovirus for the treatment of neoplasia |
| 12/12/2002 | US20020187068 Method of inactivating pathogens |
| 12/12/2002 | US20020185820 Rotating seals for cell processing systems |
| 12/12/2002 | DE10126023A1 Zusammensetzung mit therapeutischer Wirksamkeit Composition with therapeutic efficacy |
| 12/12/2002 | CA2452865A1 Conditioned cell culture media and uses thereof |
| 12/12/2002 | CA2449466A1 Peripheral blood fibrocytes differentiation pathway and migration to wound sites |
| 12/12/2002 | CA2449008A1 Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins |
| 12/12/2002 | CA2448591A1 T cell induced tissue repair and regeneration |
| 12/12/2002 | CA2448066A1 Chimeric alphavirus replicon particles |
| 12/12/2002 | CA2446929A1 Orally administering parathyroid hormone and calcitonin |
| 12/11/2002 | WO2002000231A1 Use of a formulation made of or containing at least one dissimilated milk serum |
| 12/11/2002 | EP1264893A1 CLA biosynthesis by bifidobacteria |
| 12/11/2002 | EP1264889A1 Chicken leukemia inhibitory factor (LIF) and the gene thereof |
| 12/11/2002 | EP1264884A1 Method of controlling telomere length |
| 12/11/2002 | EP1264879A1 Isolation of a cluster of cells from an isolated organ using magnetic particle |
| 12/11/2002 | EP1264612A1 Method for nasal application of a medicinal substance |
| 12/11/2002 | EP1263954A2 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 12/11/2002 | EP1263936A1 Altered strain of the modified vaccinia virus ankara (mva) |
| 12/11/2002 | EP1263933A2 Treatment for bone disorders |
| 12/11/2002 | EP1263932A1 Embryonic stem cells and neural progenitor cells derived therefrom |
| 12/11/2002 | EP1263931A2 Augmentation and repair of age-related soft tissue defects |
| 12/11/2002 | EP1263930A1 Human cord blood as a source of neural tissue for repair of the brain and spinal cord |
| 12/11/2002 | EP1263929A2 Artificial bone chips, methods for the production thereof and their use |
| 12/11/2002 | EP1263928A1 Cytotoxic t lymphocytes activated by dendritic cell hybrids |
| 12/11/2002 | EP1263521A2 A method of sorting cells |
| 12/11/2002 | EP1263474A1 A method of sensitising endothelial cells to prodrugs |
| 12/11/2002 | EP1263462A1 Human herpesvirus 6a and 6b transfer factors for the treatment of chronic fatigue syndrome and multiple sclerosis |
| 12/11/2002 | EP1263461A1 Adenovirus formulations |
| 12/11/2002 | EP1263456A2 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia" |
| 12/11/2002 | EP1263449A1 Induction of beta cell differentiation in human cells by stimulation of the glp-1 receptor |
| 12/11/2002 | EP1263448A1 Maca and antler for augmenting testosterone levels |
| 12/11/2002 | EP1263418A2 Cartilage enhancing food supplements and methods of preparing the same |
| 12/11/2002 | EP1263365A1 Malleable paste with allograft bone reinforcement for filling bone defects |
| 12/11/2002 | EP0894001B1 Inhibitor of immunoglobulin e antibody production for the treatment of type i allergy-related diseases |
| 12/11/2002 | EP0802985B1 Cell cycle regulated repressor and dna element |
| 12/11/2002 | EP0754052B1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound |
| 12/11/2002 | CN1384885A Prep. of recombinant adenoviruses and adenovirus banks |
| 12/11/2002 | CN1384884A Herpes virus vectors for dendritic cells |
| 12/11/2002 | CN1384883A Production of recombinant respiratory syncytical viruses expressing immune modulatory molecules |